The Rainbow Study - the Effect of Feedback on Asthmatic Symptom Perception

Launched by MEDISCH SPECTRUM TWENTE · Nov 22, 2024

Keywords

ClinConnect Summary

The Rainbow Study is a clinical trial aimed at understanding how children with asthma feel and report their symptoms. Asthma can make it hard for kids to play and exercise, and sometimes they don't accurately recognize how bad their symptoms are. This study uses a special tool called the Rainbow Tool to help visualize their symptoms and lung function. Researchers want to see if regularly measuring lung function and giving personal feedback can help improve the way these children perceive their asthma symptoms.

To be eligible for the study, children must be between 7 and 15 years old and have a diagnosis of asthma from a pediatrician. They should also be able to understand Dutch and have a healthcare professional who thinks they might not be feeling their symptoms correctly. Participants will undergo lung function tests and report their symptoms throughout the study. This trial is currently looking for participants, and if your child qualifies, they may benefit from learning more about their asthma while helping researchers find better ways to manage the condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• Selection phase:
• • Pediatrician diagnosed asthma
• • Health care professional thinks perception might be poor
• • Age 7 until 15 years old
• • Adequate understanding of Dutch language
• Intervention phase:
• * Adequate number of lung function measurements + VAS scores during selection phase, defined as:
• • At least 4 measurements after exercise or when experiencing symptoms and
• • At least 2 standard measurements
• * Poor perception during selection phase, defined as:
• • At least 1 measurement in red zone on Perception Rainbow and/or
• • At least 2 measurements in orange zone on Perception Rainbow and/or
• • Average of all measurements after exercise or when experiencing symptoms in yellow zone (or orange/red)and/or
• • Average of all measurements in yellow zone (or orange/red)
• Exclusion Criteria:
• • Severe comorbidity (for example psychomotor retardation or severe cardiopulmonary conditions)
• • Not able to fill in VAS score (for example due to blindness)
• • Not able to perform technically correct spirometry manoeuvres
• • Medication change in past 2 weeks
• • Exacerbation which required oral prednisone in the past 6 weeks
• • Exacerbation at the moment of inclusion
• • No device (computer, tablet or smartphone) with internet connection available at home